SCHEMBL22960302

SCHEMBL22960302

O=C1CSc2c1sc1ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.41
ALDH1A1 P00352 4/20 0.38
ALOX15 P16050 1/20 0.38
KDM4E B2RXH2 3/20 0.35
PRKD1 Q15139 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
PRKD3 O94806 1/20 0.34
PRKD2 Q9BZL6 1/20 0.34
HPGD P15428 1/20 0.34
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ACHE P22303 1/20 0.33
DDAH1 O94760 1/20 0.33
CASP3 P42574 1/20 0.33
HTT P42858 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22960244 0.77 PRNP (0.35) ALDH1A1KDM4ETDP1HPGDL3MBTL1
SCHEMBL12228803 0.69 GPR3 (0.55) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL23338713 0.68 GPR3 (0.43) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL1393409 0.68 GPR3 (0.43) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL3318555 0.66 GPR3 (0.50) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL23878721 0.66 HSD17B10 (0.45) GPR3ALDH1A1ALOX15KDM4EMAPT
SCHEMBL24446398 0.66 GPR3 (0.40) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL87299 0.65 ALDH1A1 (0.49) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL23621007 0.64 GPR3 (0.48) GPR3ALDH1A1ALOX15KDM4ETDP1
SCHEMBL9160474 0.64 GPR3 (0.68) GPR3ALDH1A1ALOX15KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524967-B2 Heteroacene and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-12-13 US disclosed
US-20210040112-A1 HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524967-B2 Heteroacene and organic electroluminescence device using the same POF1B, HCN1, HCN2 GPR3 4092/4885ALDH1A1 2343/4885ALOX15 945/4885
US-20210040112-A1 HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME HCN1, HCN2, CACNA1F GPR3 4160/4885ALDH1A1 2216/4885ALOX15 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.